北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 血液科  > 期刊论文
学科主题: 临床医学
题名:
Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
作者: Zhang, Xiaohui1; Zhou, Yi1; Xu, Lanping1; Han, Wei1; Chen, Huan1; Chen, Yuhong1; Fu, Haixia1; Zhou, Shiyuan1; Zhao, Jingzhong2; Wang, Qianming1; Feng, Feier1; Zhu, Xiaolu1; Liu, Kaiyan1; Huang, Xiaojun1
关键词: Allogeneic hematopoietic stem cell transplantation ; Acute graft-versus-host disease ; IL-35 ; Platelet aggregation
刊名: ANNALS OF HEMATOLOGY
发表日期: 2015-05-01
DOI: 10.1007/s00277-014-2278-7
卷: 94, 期:5, 页:837-845
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Hematology
研究领域[WOS]: Hematology
关键词[WOS]: REGULATORY T-CELLS ; VASCULAR ENDOTHELIUM ; RISK-FACTORS ; ACUTE GVHD ; MICE ; CYTOKINE ; ENCEPHALOMYELITIS ; ATHEROTHROMBOSIS ; COMPLICATIONS ; SUPPRESSION
英文摘要:

Acute graft-versus-host disease (aGVHD) is a major complication associated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). Interleukin (IL)-35 is a novel anti-inflammatory cytokine that suppresses the immune response. This prospective study explored IL-35 plasma levels in 65 patients after HSCT. The results revealed that the peripheral blood of patients with grades III-IV aGVHD (23.46 ng/ml) had reduced IL-35 compared to transplanted patients with grades I-II aGVHD (40.26 ng/ml, p < 0.01) or patients without aGVHD (41.40 ng/ml, p < 0.05). Allografts, including granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cell (PBPC) and G-CSF-primed bone marrow (GBM), from 38 patients were analyzed for IL-35 levels with respect to aGVHD. The patients who received lower levels of IL-35 cells in the GBM (28.0 ng/ml, p = 0.551) or lower levels of IL-35 in PBPC (53.46 ng/ml, p = 0.03) exhibited a higher incidence of aGVHD. Patients with aGVHD have increased platelet aggregation. IL-35 was added to patient blood in vitro, and platelet aggregation was inhibited by IL-35 in a dose-dependent manner. The markers of platelet activation (CD62P/PAC-1) can also be inhibited by IL-35. The results indicate that IL-35 may affect the development of aGVHD by inhibiting platelet activation and aggregation. Our data suggests that IL-35 represents a potentially effective therapeutic agent against aGVHD after allo-HSCT.

语种: 英语
所属项目编号: 81070449 ; 81270643 ; 7132194 ; 7112139
项目资助者: National Science Foundation of China ; Beijing Natural Science Foundation
WOS记录号: WOS:000351836900014
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/54683
Appears in Collections:北京大学第二临床医学院_血液科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China
2.Peking Univ, Peoples Hosp, Dept Lab Med, Beijing 100044, Peoples R China

Recommended Citation:
Zhang, Xiaohui,Zhou, Yi,Xu, Lanping,et al. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation[J]. ANNALS OF HEMATOLOGY,2015,94(5):837-845.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhang, Xiaohui]'s Articles
[Zhou, Yi]'s Articles
[Xu, Lanping]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhang, Xiaohui]‘s Articles
[Zhou, Yi]‘s Articles
[Xu, Lanping]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace